304 filings
Page 10 of 16
SC 13G/A
sd5e2ajvzt0ig3c
11 Feb 16
Beneficial ownership report (amended)
12:00am
6-K
u7b c4y7td
10 Feb 16
GW Pharmaceuticals plc Reports First Quarter 2016 Financial Results and Operational Progress
12:00am
6-K
x9z zpdaw
29 Dec 15
Current report (foreign)
12:00am
6-K
7rmd7lcse4gzmymsdjnp
28 Dec 15
Current report (foreign)
12:00am
6-K
5yqqjkeks
22 Dec 15
Current report (foreign)
12:00am
6-K
1ansyoi9e ee7r9
7 Dec 15
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2015 Financial Results and Operational Progress
12:00am
6-K
2ctqsbb
25 Nov 15
New Epidiolex® (CBD) Data Accepted for Presentation at the 69th Annual Meeting of the American Epilepsy Society
12:00am
6-K
tr6ywvbp1aimdk
28 Oct 15
Current report (foreign)
12:00am
6-K
ir20mfplmx47jr
16 Sep 15
GW Pharmaceuticals Announces Positive Proof of Concept Data in Schizophrenia
12:00am
6-K
qadsnf
7 Aug 15
GW Pharmaceuticals plc Reports Third Quarter 2015 Financial Results and Operational Progress
12:00am
6-K
dg3 p5gxovun
21 Jul 15
GW Pharmaceuticals Announces Appointment of Julian Gangolli to Board of Directors
12:00am
6-K
aql8bmrq2u0p1ilbta96
26 Jun 15
Current report (foreign)
12:00am
6-K
knrpe5pk
12 Jun 15
Current report (foreign)
12:00am
S-8
x4ljf lw5
22 May 15
Registration of securities for employees
12:00am
6-K
agbuh2hx3j
22 May 15
GW Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
12:00am
6-K
uts5cb7
13 May 15
GW Pharmaceuticals plc Reports Second Quarter 2015 Financial Results and Operational Progress
12:00am
SC 13G
edj0itx2d brdrvn4fd0
11 May 15
GW Pharmaceuticals PLC
12:00am
6-K
0tf3pyj28ym2pivs9y7t
7 May 15
Current report (foreign)
12:00am
6-K
7xh k3xgahys
1 May 15
Current report (foreign)
12:00am